Study of biological safety of camel milk after treatment with different antibiotics
PLOS One · 22.04.2025 · 20 (4) · e0321807
DOI: 10.1371/journal.pone.0321807 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 22.04.2025. Verfasst von Zauresh Bilal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Department, Al-Farabi Kazakh National University, Almaty, Kazakhstan. Hauptthemen laut MEDLINE: Camelus, Milk, Anti-Bacterial Agents, Drug Residues. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science of the Republic of Kazakhstan, Ministry of Agriculture of the Republic of Kazakhstan.
Abstract (Originalsprache)
The use of antibiotics in camels is generally based on the doses applied to cattle, despite the known differences in plasma pharmacokinetics between camel and cattle. The demand for camel milk increased due to the belief that traditional camel farming practices produce safe milk with health benefits. For assessing the importance of antibiotic residues in camel milk and to propose a convenient withdrawal period, a trial was conducted on 10 lactating camels (7–12 years old; 450 kg life weight (LW), 7–8 liter of milk production per day) at mid-lactation receiving an injection of 40 mL of Pen-strep® (benzylpenicillin-procaine 200,000 IU/1 ml and dihydrostreptomycin sulfate 200 mg/1 ml) and Nitox® (oxytetracycline dihydrate 200 mg/1 ml). The antibiotic residues were measured in the milk 30 min after injection then on day 1, 2, 3, 7, 9, 14, 19, 24 and 56 by using HPLC-MS/MS. Results showed that penicillin’s mean residual concentration (0.3 ± 0.013 mg/kg) remained 7.5 times above the maximum residue limit (MRL) even on 56th day. In contrast, streptomycin fell below the MRL within 30 minutes and averaged 1 µg/kg by day 56. Oxytetracycline levels exceeded the MRL (0.1 mg/kg) until day 14 but dropped to a safe level of 0.018 ± 0.01 mg/kg by day 24. In conclusion, the decline in streptomycin concentration post-injection appeared rapid and efficient, the elimination of penicillin and tetracycline was slow. These preliminary results lead to considering the necessity to adapt the waiting time to the dairy camel.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biotechnology Department, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
- LLP "Scientific and Production Enterprise Antigen", Almaty, Kazakhstan.
- Horse and Camel Breeding Department, LLP "Kazakh Research Institute for Livestock and Fodder Production", Almaty, Kazakhstan.
- Center of International Cooperation on Agriculture Research for Development-CIRAD, UMR SELMET, Campus International de Baillarguet, Montpellier, France.
ORCID-Profile: Zauresh Bilal, Farida Amutova, Askar Kondybayev, Bernard Faye, Gaukhar Konuspayeva
Förderung
- Ministry of Education and Science of the Republic of Kazakhstan
- Ministry of Agriculture of the Republic of Kazakhstan
Zitieren
APA
Bilal, Z., Amutova, F., Kabdullina, Z., Utemuratova, D., Kondybayev, A., Akhmetsadykova, S., Musayev, Z., Akhmetsadykov, N., Faye, B., & Konuspayeva, G. (2025). Study of biological safety of camel milk after treatment with different antibiotics. PLOS One, 20(4), e0321807. https://doi.org/10.1371/journal.pone.0321807
Vancouver
Bilal Z, Amutova F, Kabdullina Z, Utemuratova D, Kondybayev A, Akhmetsadykova S, et al. Study of biological safety of camel milk after treatment with different antibiotics. PLOS One. 2025;20(4):e0321807. doi:10.1371/journal.pone.0321807
BibTeX
@article{Bilal2025,
author = {Bilal, Zauresh and Amutova, Farida and Kabdullina, Zaira and Utemuratova, Dariga and Kondybayev, Askar and Akhmetsadykova, Shynar and Musayev, Zhaidar and Akhmetsadykov, Nurlan and Faye, Bernard and Konuspayeva, Gaukhar},
title = {Study of biological safety of camel milk after treatment with different antibiotics},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {4},
pages = {e0321807},
doi = {10.1371/journal.pone.0321807}
}
EUVIMED